Diagnostics and analysis of SARS-CoV-2: current status, recent

Two Years into the COVID-19 Pandemic: Lessons Learned

Coronavirus

Mild or Moderate Covid-19

Quest Diagnostics Newsroom - News Releases

Frontiers SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and Beyond

Diagnostic assay and technology advancement for detecting SARS-CoV-2 infections causing the COVID-19 pandemic

Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives - Chemical Science (RSC Publishing) DOI:10.1039/D2SC06665C

Xpert® Xpress SARS-CoV-2 - FDA Emergency Use Authorization

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021

SAVE—NIAID's 'Avengers-Like' Research Program for Evolving Pathogens